適時開示情報
- 2025/04/16
- Notice of Issuance of New Shares Under RSU Plan and Determination of Pmt Amount and Other Matters of Issuance of New Shares Under Previous Years’ RSU
- 2025/03/25
- Nxera Pharma’s Partner Tempero Bio Initiates Phase 2 Trial with TMP-301 for Alcohol Use Disorder
TD-net(適時開示情報閲覧サービス)にて開示された情報を掲載しております。